Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Intrapartum care

NICE guideline
Reference number: NG235
Published: 29 September 2023
Last updated: 18 June 2025

History

Guidance published

Equality and health inequalities assessment Final (PDF 118 KB)

Published:

18 June 2025
Committee member list (PDF 116 KB)

Published:

18 June 2025
Consultation comments and responses (PDF 241 KB)

Published:

18 June 2025
Supporting documentation - Acknowledgements (PDF 159 KB)

Published:

18 June 2025

Stakeholder list updated

Stakeholder list (PDF 48 KB)

Published:

17 June 2025

Draft guidance consultation

Draft guidance consultation
Equality and health inequalities assessment (downloadable version) (PDF 166 KB)

Published:

31 March 2025
Draft guideline (downloadable version) (PDF 163 KB)

Published:

31 March 2025
Committee member list (PDF 116 KB)

Published:

31 March 2025
Supporting documentation (downloadable version) (PDF 446 KB)

Published:

31 March 2025
Supporting documentation (downloadable version) (PDF 344 KB)

Published:

31 March 2025
Comments form (MSWord 51 KB)

Published:

31 March 2025
Comments form (MSWord 51 KB)

Published:

31 March 2025

Committee meetings

Committee meeting
Minutes (PDF 315 KB)

Published:

24 September 2024
WRHS Minutes GC50 (PDF 169 KB)

Published:

01 May 2025

Update on 03 December 2024

Guidance published
Consultation comments and responses (PDF 365 KB)

Published:

03 December 2024
Committee member list (PDF 152 KB)

Published:

03 December 2024
Equality and health inequalities assessment (PDF 226 KB)

Published:

03 December 2024
Stakeholder list updated
Stakeholder list (PDF 48 KB)

Published:

02 December 2024
Declaration of interests
Register of interests (PDF 699 KB)

Published:

02 December 2024
Draft guidance consultation
Draft guidance consultation
Comments form (MSWord 41 KB)

Published:

07 October 2024
Evidence review O (PDF 2.63 MB)

Published:

07 October 2024
Equality and health inequalities assessment (downloadable version) (PDF 190 KB)

Published:

07 October 2024
Draft guideline (downloadable version) (PDF 202 KB)

Published:

07 October 2024
Committee member list (PDF 176 KB)

Published:

07 October 2024
DOI register (PDF 1.32 MB)

Published:

07 October 2024
Committee meeting: 46
Minutes (PDF 202 KB)

Published:

07 October 2024
Committee meeting: 48
Minutes (PDF 288 KB)

Published:

07 October 2024

Original development on 29 September 2023

Guidance published
Consultation comments and responses (PDF 2.37 MB)

Published:

29 September 2023
Equality impact assessment Final (PDF 231 KB)

Published:

29 September 2023
Committee member list (PDF 160 KB)

Published:

29 September 2023
Stakeholder list updated
Stakeholder list (PDF 202 KB)

Published:

28 September 2023
Declaration of interests
Register of interests (PDF 607 KB)

Published:

19 January 2024
Draft guidance consultation
Draft guidance consultation
Comments form (MSWord 41 KB)

Published:

25 April 2023
Evidence review A (PDF 910 KB)

Published:

25 April 2023
Evidence review B (PDF 480 KB)

Published:

25 April 2023
Evidence review C (PDF 1.48 MB)

Published:

25 April 2023
Evidence review D (PDF 1.55 MB)

Published:

25 April 2023
Evidence review E (PDF 1.21 MB)

Published:

25 April 2023
Evidence review F (PDF 1.12 MB)

Published:

25 April 2023
Evidence review G (PDF 1.7 MB)

Published:

25 April 2023
Evidence review H (PDF 1.22 MB)

Published:

25 April 2023
Evidence review I (PDF 1.02 MB)

Published:

25 April 2023
Evidence review J (PDF 785 KB)

Published:

25 April 2023
Evidence review K (PDF 887 KB)

Published:

25 April 2023
Evidence review L (PDF 1.12 MB)

Published:

25 April 2023
Evidence review M (PDF 3.64 MB)

Published:

25 April 2023
Evidence review N (PDF 925 KB)

Published:

25 April 2023
Evidence review O (PDF 1.31 MB)

Published:

25 April 2023
Draft guideline (PDF 1.19 MB)

Published:

25 April 2023
Comments form (MSWord 41 KB)

Published:

25 April 2023
Supporting documentation 1 (PDF 469 KB)

Published:

25 April 2023
Supporting documentation 2 (PDF 462 KB)

Published:

25 April 2023
Supporting documentation 3 (PDF 285 KB)

Published:

25 April 2023
Supporting documentation 4 (PDF 6.48 MB)

Published:

25 April 2023
Supporting documentation 5 (PDF 955 KB)

Published:

25 April 2023
Supporting documentation 6 (PDF 166 KB)

Published:

25 April 2023
Supporting documentation Algorithm (PDF 121 KB)

Published:

25 April 2023
Equality impact assessment (PDF 118 KB)

Published:

25 April 2023
Pre-consultation documents released
Economic plan (PDF 126 KB)

Published:

03 March 2023
Review questions (PDF 175 KB)

Published:

03 March 2023
Scope published
Consultation comments and responses (PDF 1.03 MB)

Published:

18 March 2021
Equality impact assessment 2 (PDF 114 KB)

Published:

18 March 2021
Committee member list (PDF 160 KB)

Published:

18 March 2021
Final scope (PDF 133 KB)

Published:

18 March 2021
Draft scope consultation
Draft scope consultation
Committee member list (PDF 136 KB)

Published:

07 January 2021
Draft scope (PDF 333 KB)

Published:

07 January 2021
Equality impact assessment 1 (PDF 145 KB)

Published:

07 January 2021
Comments form (MSWord 34 KB)

Published:

07 January 2021
Committee meeting
Minutes 16 (PDF 167 KB)

Published:

03 March 2021
Minutes 17 (PDF 183 KB)

Published:

11 May 2021
Minutes 18 (PDF 193 KB)

Published:

11 June 2021
Minutes 19 (PDF 177 KB)

Published:

05 July 2021
Minutes 21 (PDF 199 KB)

Published:

31 August 2021
Minutes 22 (PDF 171 KB)

Published:

27 September 2021
Minutes 23 (PDF 197 KB)

Published:

02 November 2021
Minutes 24 (PDF 183 KB)

Published:

10 December 2021
Minutes 25 (PDF 163 KB)

Published:

31 January 2022
Minutes 26 (PDF 178 KB)

Published:

10 March 2022
Minutes 27 (PDF 167 KB)

Published:

31 March 2022
Minutes 28 (PDF 175 KB)

Published:

25 April 2022
Minutes 29 (PDF 207 KB)

Published:

10 June 2022
Minutes 30 (PDF 188 KB)

Published:

21 July 2022
Minutes 31 (PDF 252 KB)

Published:

06 September 2022
Minutes 32 (MSWord 99 KB)

Published:

18 October 2022
Minutes 33 (PDF 197 KB)

Published:

23 November 2022
Minutes 34 (PDF 186 KB)

Published:

03 February 2023
Minutes 37 (PDF 272 KB)

Published:

21 June 2023